Health Care

Up-To-Date Stocks Report: Rock Creek Pharmaceuticals, Inc. (PNK:RCPI), Quest Diagnostics Incorporated (NYSE:DGX)

0 3

Rock Creek Pharmaceuticals, Inc. (PNK:RCPI) closed its last session at $0.0114 with the change of -2.5641%. The market capitalization of the company is $276108.00 with an average Volume of 7.28 million shares. The stock currently has its 52-Week High range of $1.5600 and 52-week low range of $0.0092. The stock traded total quantity of 11.77 million shares.

The Company currently has Highest Price Target of $4 and Lowest Price Target of $4. It has Median Price Targets of $4. Mean price target is set at $4 after consensus analysis of 1 brokers.

When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 0 analysts have assigned this stock as Strong Buy where 1 assigned Buy, 0 analysts believe it’s a Hold, 0 said Underperform and 0 assigned Sell rating.

Quest Diagnostics Incorporated (NYSE:DGX) ended its last trade at $82.23 with the move of +1.23%. The company has market value of $11.63B with the total traded volume of 1.52 million. The stock currently has its 52-Week top value of $82.42 and 52-week down value of $59.66. The price to book (P/B) ratio of the company is 2.47. Its previous closing price was recorded at $81.23.

For the current Fiscal Quarter, 20 analysts have given an Average earnings estimate of $1.32 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $1.28 while High Estimate is $1.35. The Previous Year EPS of this Quarter is $1.25.

 

According to 18 analysts, an Average Revenue Estimate of the current Fiscal quarter is $1.91B. According to them, the Low Revenue estimate is $1.88B and High Revenue estimate is $1.94B.

 

The Company currently has High Price Target of $84. The Low and Mean Price Targets are $70 and $75.8 respectively. These price targets are set after consensus analysis of 15 brokers.

 

When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month, 1 analysts have given this stock as Strong Buy where 2 issued Buy, 17 analysts think that it’s a Hold, 2 told Underperform and0 assigned Sell rating.

 

 

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

Advirtisement

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter